Logo image of INGN

INOGEN INC (INGN) Stock Fundamental Analysis

NASDAQ:INGN - Nasdaq - US45780L1044 - Common Stock - Currency: USD

6.55  -0.16 (-2.38%)

After market: 6.55 0 (0%)

Fundamental Rating

3

Overall INGN gets a fundamental rating of 3 out of 10. We evaluated INGN against 187 industry peers in the Health Care Equipment & Supplies industry. While INGN seems to be doing ok healthwise, there are quite some concerns on its profitability. INGN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year INGN has reported negative net income.
In the past year INGN has reported a negative cash flow from operations.
In the past 5 years INGN always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: INGN reported negative operating cash flow in multiple years.
INGN Yearly Net Income VS EBIT VS OCF VS FCFINGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

INGN has a better Return On Assets (-8.91%) than 62.57% of its industry peers.
Looking at the Return On Equity, with a value of -13.88%, INGN is in the better half of the industry, outperforming 65.24% of the companies in the same industry.
Industry RankSector Rank
ROA -8.91%
ROE -13.88%
ROIC N/A
ROA(3y)-21.41%
ROA(5y)-13.35%
ROE(3y)-32.95%
ROE(5y)-20.44%
ROIC(3y)N/A
ROIC(5y)N/A
INGN Yearly ROA, ROE, ROICINGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

Looking at the Gross Margin, with a value of 46.11%, INGN is doing worse than 60.43% of the companies in the same industry.
In the last couple of years the Gross Margin of INGN has remained more or less at the same level.
INGN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.22%
GM growth 5Y-0.6%
INGN Yearly Profit, Operating, Gross MarginsINGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

6

2. Health

2.1 Basic Checks

INGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for INGN has been increased compared to 1 year ago.
INGN has more shares outstanding than it did 5 years ago.
There is no outstanding debt for INGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
INGN Yearly Shares OutstandingINGN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
INGN Yearly Total Debt VS Total AssetsINGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

INGN has an Altman-Z score of 1.56. This is a bad value and indicates that INGN is not financially healthy and even has some risk of bankruptcy.
INGN has a Altman-Z score of 1.56. This is comparable to the rest of the industry: INGN outperforms 56.15% of its industry peers.
INGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.56
ROIC/WACCN/A
WACC9.07%
INGN Yearly LT Debt VS Equity VS FCFINGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 3.07 indicates that INGN has no problem at all paying its short term obligations.
INGN has a Current ratio (3.07) which is comparable to the rest of the industry.
A Quick Ratio of 2.67 indicates that INGN has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.67, INGN is in the better half of the industry, outperforming 60.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.07
Quick Ratio 2.67
INGN Yearly Current Assets VS Current LiabilitesINGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

INGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 57.88%, which is quite impressive.
The Revenue has been growing slightly by 5.73% in the past year.
INGN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.49% yearly.
EPS 1Y (TTM)57.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.68%
Revenue 1Y (TTM)5.73%
Revenue growth 3Y-2.12%
Revenue growth 5Y-1.49%
Sales Q2Q%5.45%

3.2 Future

The Earnings Per Share is expected to grow by 16.18% on average over the next years. This is quite good.
Based on estimates for the next years, INGN will show a small growth in Revenue. The Revenue will grow by 6.30% on average per year.
EPS Next Y30.43%
EPS Next 2Y19.94%
EPS Next 3Y16.18%
EPS Next 5YN/A
Revenue Next Year7.3%
Revenue Next 2Y6.76%
Revenue Next 3Y6.3%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
INGN Yearly Revenue VS EstimatesINGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
INGN Yearly EPS VS EstimatesINGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INGN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for INGN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INGN Price Earnings VS Forward Price EarningsINGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INGN Per share dataINGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as INGN's earnings are expected to grow with 16.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.94%
EPS Next 3Y16.18%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for INGN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INOGEN INC

NASDAQ:INGN (7/15/2025, 8:00:02 PM)

After market: 6.55 0 (0%)

6.55

-0.16 (-2.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners73.13%
Inst Owner Change0%
Ins Owners2.07%
Ins Owner Change9.65%
Market Cap176.13M
Analysts77.78
Price Target13.26 (102.44%)
Short Float %4.28%
Short Ratio4.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.35%
Min EPS beat(2)33.97%
Max EPS beat(2)50.73%
EPS beat(4)4
Avg EPS beat(4)48%
Min EPS beat(4)33.97%
Max EPS beat(4)56.83%
EPS beat(8)6
Avg EPS beat(8)19.27%
EPS beat(12)9
Avg EPS beat(12)22.62%
EPS beat(16)11
Avg EPS beat(16)50.76%
Revenue beat(2)2
Avg Revenue beat(2)3.81%
Min Revenue beat(2)1.4%
Max Revenue beat(2)6.23%
Revenue beat(4)4
Avg Revenue beat(4)4.16%
Min Revenue beat(4)1.4%
Max Revenue beat(4)6.23%
Revenue beat(8)5
Avg Revenue beat(8)0.73%
Revenue beat(12)7
Avg Revenue beat(12)0.29%
Revenue beat(16)10
Avg Revenue beat(16)1.41%
PT rev (1m)8.33%
PT rev (3m)30%
EPS NQ rev (1m)6.98%
EPS NQ rev (3m)3.9%
EPS NY rev (1m)7.03%
EPS NY rev (3m)25.15%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)-2.29%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.52
P/FCF N/A
P/OCF N/A
P/B 0.89
P/tB 1.13
EV/EBITDA N/A
EPS(TTM)-1.15
EYN/A
EPS(NY)-0.85
Fwd EYN/A
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS12.64
BVpS7.36
TBVpS5.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.91%
ROE -13.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.11%
FCFM N/A
ROA(3y)-21.41%
ROA(5y)-13.35%
ROE(3y)-32.95%
ROE(5y)-20.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.22%
GM growth 5Y-0.6%
F-Score6
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 71.68%
Cap/Sales 4.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.07
Quick Ratio 2.67
Altman-Z 1.56
F-Score6
WACC9.07%
ROIC/WACCN/A
Cap/Depr(3y)106.82%
Cap/Depr(5y)105.29%
Cap/Sales(3y)6.42%
Cap/Sales(5y)6.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.68%
EPS Next Y30.43%
EPS Next 2Y19.94%
EPS Next 3Y16.18%
EPS Next 5YN/A
Revenue 1Y (TTM)5.73%
Revenue growth 3Y-2.12%
Revenue growth 5Y-1.49%
Sales Q2Q%5.45%
Revenue Next Year7.3%
Revenue Next 2Y6.76%
Revenue Next 3Y6.3%
Revenue Next 5YN/A
EBIT growth 1Y55.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100%
EBIT Next 3Y29.04%
EBIT Next 5YN/A
FCF growth 1Y57.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.19%
OCF growth 3Y-36.98%
OCF growth 5Y-31.97%